The top 8 Healthcare Funds stocks to keep in your portfolio in November 2019

IShares [IEIH] is traded in USA and was established 2018-03-21. The fund is listed under Health category and is part of iShares family. IShares currently have 36.3 M in assets under management (AUM). , while the total return for the last 3 years was 13.67%.

Allianzgi Health Sciences [RAGHX] is traded in USA and was established 24th of April 2024. Allianzgi Health is listed under Allianz Global Investors category by Fama And French industry classification. The fund is listed under Health category and is part of Allianz Global Investors family. The entity is thematically classified as Healthcare Funds. This fund at this time has accumulated 175.34 M in assets with no minimum investment requirementsAllianzgi Health Sciences is currently producing year-to-date (YTD) return of 3.14%, while the total return for the last 3 years was 2.92%.

Health Care Fund [RYHEX] is traded in USA and was established 24th of April 2024. Health Care is listed under Rydex Funds category by Fama And French industry classification. The fund is listed under Health category and is part of Rydex Funds family. This fund at this time has accumulated 26.49 M in assets with minimum initial investment of 2.5 K. Health Care Fund is currently producing year-to-date (YTD) return of 1.34%, while the total return for the last 3 years was 1.32%. At this time, the entity appears to be fairly valued. Health Care Fund retains a regular Real Value of $36.3 per share. The prevalent price of the fund is $36.57. We determine the value of Health Care Fund from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.

Biotechnology Fund Investor [RYOIX] is traded in USA and was established 24th of April 2024. Biotechnology Fund is listed under Rydex Funds category by Fama And French industry classification. The fund is listed under Health category and is part of Rydex Funds family. This fund at this time has accumulated 117.21 M in assets with no minimum investment requirementsBiotechnology Fund is currently producing year-to-date (YTD) return of 0.53%, while the total return for the last 3 years was -4.95%.

Deutsche Health And [SCHLX] is traded in USA and was established 24th of April 2024. Deutsche Health is listed under DWS category by Fama And French industry classification. The fund is listed under Health category and is part of DWS family. The entity is thematically classified as Healthcare Funds. This fund at this time has accumulated 318.86 M in assets with no minimum investment requirementsDeutsche Health And is currently producing year-to-date (YTD) return of 1.82%, while the total return for the last 3 years was 3.77%. At this time, the entity appears to be fairly valued. Deutsche Health And shows a prevailing Real Value of $41.24 per share. The current price of the fund is $41.15. We determine the value of Deutsche Health And from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.

First Trust Nasdaq [FTXH] is traded in USA and was established 2016-09-20. The fund is listed under Health category and is part of First Trust family. The entity is thematically classified as Sector ETFs. First Trust Nasdaq currently have 36.04 M in assets under management (AUM). , while the total return for the last 3 years was 1.4%.

Invesco Dynamic Pharmaceuticals [PJP] is traded in USA and was established 2005-06-23. The fund is classified under Health category within Invesco family. The entity is thematically classified as Sector ETFs. Invesco Dynamic Phar at this time have 302.14 M in assets. , while the total return for the last 3 years was -0.4%. At this time, the entity appears to be fairly valued. Invesco Dynamic Phar retains a regular Real Value of $76.44 per share. The prevalent price of the entity is $76.4. Our model calculates the value of Invesco Dynamic Phar from evaluating the entity fundamentals such as Price To Book of 2.03 X, return on equity of 1.0E-4, and Return On Asset of 1.02 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage buying undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together.

SPDR SP Pharmaceuticals [XPH] is traded in USA and was established 2006-06-19. The fund is classified under Health category within SPDR State Street Global Advisors family. The entity is thematically classified as Sector ETFs. SPDR SP Pharmaceuticals at this time have 206.63 M in net assets. , while the total return for the last 3 years was -5.5%.